In the first study on elephant seals, published today in Nature Communications, researchers from UC Davis and the National ...

周四，Oppenheimer 对 Terns Pharmaceuticals (NASDAQ: TERN) 股票启动覆盖，给予"跑赢大盘"评级，并设定目标价为17.00美元。该公司分析师对公司的临床管线表示信心，特别强调了两个主要资产：用于慢性髓性白血病(CML)的TERN-701和用于肥胖症的TERN-601。 分析师指出，TERN-701是一种酪氨酸激酶抑制剂(TKI)，在剂量和耐受性方面可能 ...

Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing ...

A 2023 avian flu outbreak decimated a Caspian tern colony on Rat Island and spread to harbor seals, posing a new threat to local wildlife. A 2023 epidemiological study revealed that 56% of a large ...

An epidemiological study found that 56% of a large breeding colony of Caspian terns died from a 2023 outbreak of highly ...

Shares of biotech concern Terns Pharmaceuticals, Inc. (NASDAQ:TERN) are up somewhat higher since we first examined it in September of 2022, riding optimism concerning two early-stage clinical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Friday, Terns Pharmaceuticals Inc (TERN) stock saw a modest uptick, ending the day at $6.94 which represents a slight increase of $0.08 or 1.17% from the prior close of $6.86. The stock opened at ...

Oppenheimer initiated coverage of Terns Pharmaceuticals (TERN) with an Outperform rating and $82 price target Published first on TheFly ...

Fintel reports that on October 31, 2024, Oppenheimer initiated coverage of Terns Pharmaceuticals (NasdaqGS:TERN) with a ...

Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on TERN stock, giving a Buy rating yesterday. Graig ...

Photo / Jacob Ball The Department of Conservation has rejected criticism of its call for private and philanthropic funding to ...